Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 21, 2012 - Issue 6
Submit an article Journal homepage
445
Views
19
CrossRef citations to date
0
Altmetric
Drug Evaluations

A potential role for nilotinib in KIT-mutated melanoma

An TranUniversity of Pittsburgh, School of Medicine, Division of Hematology/Oncology, Department of Medicine, Pittsburgh, PA, USA
&
Hussein A TawbiUniversity of Pittsburgh, School of Medicine, Division of Hematology/Oncology, Department of Medicine, Pittsburgh, PA, USA;University of Pittsburgh Cancer Institute, Clinical & Translational Science, Melanoma Program, 5150 Centre Avenue, Pittsburgh, PA 15232, USA+1 412 648 6466; +1 412 648 6579; [email protected]
, MD PhD
Pages 861-869 | Published online: 16 Apr 2012

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Matias E Valsecchi & Takami Sato. (2013) The potential role of sunitinib targeting melanomas. Expert Opinion on Investigational Drugs 22:11, pages 1473-1483.
Read now

Articles from other publishers (18)

Abu Sayeed Md. Ripon Rouf, Md. Al Amin, Md. Khairul Islam, Farzana Haque, Kazi Rejvee Ahmed, Md. Ataur Rahman, Md. Zahidul Islam & Bonglee Kim. (2022) Statistical Bioinformatics to Uncover the Underlying Biological Mechanisms That Linked Smoking with Type 2 Diabetes Patients Using Transcritpomic and GWAS Analysis. Molecules 27:14, pages 4390.
Crossref
Chi Yan, Chengzhi Zhao, Ke Yang, Hongyan Zhou, Limin Jing, Weixing Zhao, Wenguang Dou, Qingxin Xia, Jie Ma, Bing Wei & Yongjun Guo. (2022) Rare c-KIT c.1926delA and c.1936T>G Mutations in Exon 13 Define Imatinib Resistance in Gastrointestinal Stromal Tumors and Melanoma Patients: Case Reports and Cell Experiments. Frontiers in Molecular Biosciences 9.
Crossref
Melissa A. Wilson & Leslie A. Fecher. (2021) The Role of Systemic Therapy in Advanced Cutaneous Melanoma of the Head and Neck. Otolaryngologic Clinics of North America 54:2, pages 329-342.
Crossref
Kirill I. Kirsanov, Ekaterina A. Lesovaya, Timur I. Fetisov, Beniamin Yu Bokhyan, Gennady A. Belitsky & Marianna G. Yakubovskaya. (2020) Current Approaches for Personalized Therapy of Soft Tissue Sarcomas. Sarcoma 2020, pages 1-15.
Crossref
Dean D. Metcalfe, Do-Kyun Kim & Ana Olivera. 2020. Mastocytosis. Mastocytosis 1 22 .
Shao‐Ping Chang, Huei‐Mei Huang, Shing‐Chuan Shen, Woan‐Ruoh Lee & Yen‐Chou Chen. (2018) Nilotinib induction of melanogenesis via reactive oxygen species‐dependent JNK activation in B16F0 mouse melanoma cells. Experimental Dermatology 27:12, pages 1388-1394.
Crossref
Florentia Dimitriou, Regina Krattinger, Egle Ramelyte, Marjam J. Barysch, Sara Micaletto, Reinhard Dummer & Simone M. Goldinger. (2018) The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe. Current Oncology Reports 20:11.
Crossref
A Jain, R Tripathi, C P Turpin, C Wang & R Plattner. (2017) Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma. Oncogene 36:32, pages 4585-4596.
Crossref
Carla Murer, Pascale Kränzlin-Stieger, Lars E. French, Reinhard Dummer & Simone M. Goldinger. (2017) Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case report. Melanoma Research 27:4, pages 396-398.
Crossref
Myke R. Green, Michael D. Newton & Karen M. Fancher. (2016) Off-Target Effects of BCR-ABL and JAK2 Inhibitors. American Journal of Clinical Oncology 39:1, pages 76-84.
Crossref
Lili Mao & Jun Guo. 2016. Brain Metastases from Primary Tumors, Volume 3. Brain Metastases from Primary Tumors, Volume 3 157 167 .
Mengze Hao, Fengju Song, Xiaoling Du, Guowen Wang, Yun Yang, Kexin Chen & Jilong Yang. (2015) Advances in targeted therapy for unresectable melanoma: New drugs and combinations. Cancer Letters 359:1, pages 1-8.
Crossref
Joo Hyun LeeJin Hee KangBaik Kee ChoHyun Jeong Park. (2015) Dysplastic Nevus with Eruptive Melanocytic Lesions That Developed during Nilotinib Therapy for Chronic Myeloid Leukemia. Annals of Dermatology 27:6, pages 782.
Crossref
Glenn Cruse, Dean D. Metcalfe & Ana Olivera. (2014) Functional Deregulation of KIT. Immunology and Allergy Clinics of North America 34:2, pages 219-237.
Crossref
Gregory A. Hosler & Kathleen M. MurphyGregory A. Hosler & Kathleen M. Murphy. 2014. Molecular Diagnostics for Dermatology. Molecular Diagnostics for Dermatology 341 354 .
. (2013) Current World Literature. Current Opinion in Oncology 25:2, pages 205-212.
Crossref
Clifton Ming Tay, Chee Wee Ong, Victor Kwan Min Lee & Brendan Pang. (2013) KIT gene mutation analysis in solid tumours: biology, clincial applications and trends in diagnostic reporting. Pathology 45:2, pages 127-137.
Crossref
V. Broshtilova & M. Balabanova. (2013) Cross Skin Reactivity to Tyrosine Kinase Inhibitors in a Patient with Chronic Myelogenous Leukemia. Journal of Cancer Therapy 04:07, pages 1141-1144.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.